159 related articles for article (PubMed ID: 19885038)
1. Flavone Attenuates Vascular Contractions by Inhibiting RhoA/Rho Kinase Pathway.
Baek I; Jeon SB; Song MJ; Yang E; Sohn UD; Kim IK
Korean J Physiol Pharmacol; 2009 Jun; 13(3):201-7. PubMed ID: 19885038
[TBL] [Abstract][Full Text] [Related]
2. Isoflavone attenuates vascular contraction through inhibition of the RhoA/Rho-kinase signaling pathway.
Seok YM; Baek I; Kim YH; Jeong YS; Lee IJ; Shin DH; Hwang YH; Kim IK
J Pharmacol Exp Ther; 2008 Sep; 326(3):991-8. PubMed ID: 18577703
[TBL] [Abstract][Full Text] [Related]
3. Effects of magnolol on vascular contraction in rat aortic rings.
Seok YM; Kim HY; Garmaa O; Cha BY; Woo JT; Kim IK
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):28-36. PubMed ID: 22004427
[TBL] [Abstract][Full Text] [Related]
4. Fluoride induces vascular contraction through activation of RhoA/Rho kinase pathway in isolated rat aortas.
Yang E; Jeon SB; Baek I; Song MJ; Yoon YR; Kim IK
Environ Toxicol Pharmacol; 2010 May; 29(3):290-6. PubMed ID: 21787615
[TBL] [Abstract][Full Text] [Related]
5. Honokiol attenuates vascular contraction through the inhibition of the RhoA/Rho-kinase signalling pathway in rat aortic rings.
Seok YM; Cho HJ; Cha BY; Woo JT; Kim IK
J Pharm Pharmacol; 2011 Sep; 63(9):1244-51. PubMed ID: 21827498
[TBL] [Abstract][Full Text] [Related]
6. 17beta-estradiol attenuates vascular contraction through inhibition of RhoA/Rho kinase pathway.
Yang E; Jeon SB; Baek I; Chen ZA; Jin Z; Kim IK
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jul; 380(1):35-44. PubMed ID: 19296091
[TBL] [Abstract][Full Text] [Related]
7. Flavone inhibits vascular contraction by decreasing phosphorylation of the myosin phosphatase target subunit.
Jeon SB; Kim G; Kim JI; Seok YM; Kim SH; Suk K; Shin HM; Lee YH; Kim IK
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1116-20. PubMed ID: 17880363
[TBL] [Abstract][Full Text] [Related]
8. Effects of gomisin A on vascular contraction in rat aortic rings.
Seok YM; Choi YW; Kim GD; Kim HY; Takuwa Y; Kim IK
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):45-56. PubMed ID: 21058010
[TBL] [Abstract][Full Text] [Related]
9. Effects of 3',4'-dihydroxyflavonol on vascular contractions of rat aortic rings.
Song MJ; Baek I; Seo M; Kim SH; Suk K; Woodman OL; Williams SJ; Kim IK
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):803-10. PubMed ID: 20374259
[TBL] [Abstract][Full Text] [Related]
10. Effects of glyceollin I on vascular contraction in rat aorta.
Song MJ; Baek I; Jeon SB; Seo M; Kim YH; Cui S; Jeong YS; Lee IJ; Shin DH; Hwang YH; Kim IK
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):517-28. PubMed ID: 20354679
[TBL] [Abstract][Full Text] [Related]
11. A role for Rho-kinase in Ca-independent contractions induced by phorbol-12,13-dibutyrate.
Baek I; Jeon SB; Kim J; Seok YM; Song MJ; Chae SC; Jun JE; Park WH; Kim IK
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):256-61. PubMed ID: 18986333
[TBL] [Abstract][Full Text] [Related]
12. Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction.
Tsai MH; Jiang MJ
Pflugers Arch; 2006 Nov; 453(2):223-32. PubMed ID: 16953424
[TBL] [Abstract][Full Text] [Related]
13. Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway.
Murthy KS; Zhou H; Grider JR; Brautigan DL; Eto M; Makhlouf GM
Biochem J; 2003 Aug; 374(Pt 1):145-55. PubMed ID: 12733988
[TBL] [Abstract][Full Text] [Related]
14. Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation.
Qi F; Ogawa K; Tokinaga Y; Uematsu N; Minonishi T; Hatano Y
Anesth Analg; 2009 Aug; 109(2):412-7. PubMed ID: 19608811
[TBL] [Abstract][Full Text] [Related]
15. Heat shock augments myosin phosphatase target-subunit phosphorylation.
Kim JI; Jeon SB; Baek I; Seok YM; Shin HM; Kim IK
Biochem Biophys Res Commun; 2007 May; 356(3):718-22. PubMed ID: 17382904
[TBL] [Abstract][Full Text] [Related]
16. cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway.
Aburima A; Wraith KS; Raslan Z; Law R; Magwenzi S; Naseem KM
Blood; 2013 Nov; 122(20):3533-45. PubMed ID: 24100445
[TBL] [Abstract][Full Text] [Related]
17. A role for Rho kinase in vascular contraction evoked by sodium fluoride.
Jeon SB; Jin F; Kim JI; Kim SH; Suk K; Chae SC; Jun JE; Park WH; Kim IK
Biochem Biophys Res Commun; 2006 Apr; 343(1):27-33. PubMed ID: 16527249
[TBL] [Abstract][Full Text] [Related]
18. G(q)-dependent signalling by the lysophosphatidic acid receptor LPA(3) in gastric smooth muscle: reciprocal regulation of MYPT1 phosphorylation by Rho kinase and cAMP-independent PKA.
Sriwai W; Zhou H; Murthy KS
Biochem J; 2008 May; 411(3):543-51. PubMed ID: 18237278
[TBL] [Abstract][Full Text] [Related]
19. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle.
Seko T; Ito M; Kureishi Y; Okamoto R; Moriki N; Onishi K; Isaka N; Hartshorne DJ; Nakano T
Circ Res; 2003 Mar; 92(4):411-8. PubMed ID: 12600888
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.
Cao X; Luo T; Luo X; Tang Z
Hypertens Res; 2014 Sep; 37(9):803-10. PubMed ID: 24965170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
